Pulmonary Vascular Distensibility Predicts Pulmonary Hypertension Severity, Exercise Capacity, and Survival in Heart Failure

Circulation: Heart Failure

Volumn 9, Issue 6, 2016, Pages

  Malhotra, Rajeev ^a   Dhakal, Bishnu P ^a   Eisman, Aaron S ^a   Pappagianopoulos, Paul P ^b   Dress, Ashley ^b   Weiner, Rory B ^a   Baggish, Aaron L ^a   Semigran, Marc J ^a   Lewis, Gregory D ^a,b  

^a Cardiology Division   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

heart failure; mortality; physiology; pulmonary heart disease; pulmonary hypertension

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BOSENTAN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; MINERALOCORTICOID ANTAGONIST; SILDENAFIL; ANTIHYPERTENSIVE AGENT; PHOSPHODIESTERASE V INHIBITOR; VASODILATOR AGENT;

ADULT; ARTICLE; CARDIOPULMONARY EXERCISE TEST; CARDIOVASCULAR MORTALITY; CONTROLLED STUDY; EXERCISE; FEMALE; HEART FAILURE; HEART FAILURE WITH PRESERVED EJECTION FRACTION; HEART FAILURE WITH REDUCED EJECTION FRACTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART OUTPUT; HEART RIGHT VENTRICLE EJECTION FRACTION; HEART RIGHT VENTRICLE PERFORMANCE; HEMODYNAMIC MONITORING; HUMAN; LUNG ARTERY PRESSURE; LUNG BLOOD VESSEL; LUNG VASCULAR RESISTANCE; LUNG WEDGE PRESSURE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; PULMONARY VASCULAR DISTENSIBILITY; RADIONUCLIDE VENTRICULOGRAPHY; AGED; ARTERIAL PRESSURE; ARTERIAL STIFFNESS; BIOLOGICAL MODEL; CASE CONTROL STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECTS; EXERCISE TEST; EXERCISE TOLERANCE; HEART RIGHT VENTRICLE FUNCTION; HEART STROKE VOLUME; HYPERTENSION, PULMONARY; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; PATHOPHYSIOLOGY; PREDICTIVE VALUE; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; PULMONARY ARTERY; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; RISK FACTOR; SEVERITY OF ILLNESS INDEX; STATISTICAL MODEL; TIME FACTOR; TREATMENT OUTCOME;

ADULT; AGED; ANTIHYPERTENSIVE AGENTS; ARTERIAL PRESSURE; CASE-CONTROL STUDIES; DOUBLE-BLIND METHOD; EXERCISE TEST; EXERCISE TOLERANCE; FEMALE; HEART FAILURE; HUMANS; HYPERTENSION, PULMONARY; KAPLAN-MEIER ESTIMATE; LINEAR MODELS; MALE; MIDDLE AGED; MODELS, CARDIOVASCULAR; MULTIVARIATE ANALYSIS; PHOSPHODIESTERASE 5 INHIBITORS; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; PULMONARY ARTERY; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SILDENAFIL CITRATE; STROKE VOLUME; TIME FACTORS; TREATMENT OUTCOME; VASCULAR STIFFNESS; VASODILATOR AGENTS; VENTRICULAR FUNCTION, RIGHT;

EID: 84975806628     PISSN: 19413289     EISSN: 19413297     Source Type: Journal    
DOI: 10.1161/CIRCHEARTFAILURE.115.003011     Document Type: Article

References (50)

1. Fang JC, DeMarco T, Givertz MM, Borlaug BA, Lewis GD, Rame JE, Gomberg-Maitland M, Murali S, Frantz RP, McGlothlin D, Horn EM, Benza RL, World Health Organization Pulmonary Hypertension group 2: pulmonary hypertension due to left heart disease in the adult-a summary statement from the Pulmonary Hypertension Council of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant 2012 31 913 933. doi: 10.1016/j.healun.2012.06.002
2. Lewis GD, Bossone E, Naeije R, Grünig E, Saggar R, Lancellotti P, Ghio S, Varga J, Rajagopalan S, Oudiz R, Rubenfire M, Pulmonary vascular hemodynamic response to exercise in cardiopulmonary diseases. Circulation 2013 128 1470 1479. doi: 10.1161/CIRCULATIONAHA.112.000667
3. Benza RL, Raina A, Abraham WT, Adamson PB, Lindenfeld J, Miller AB, Bourge RC, Bauman J, Yadav J, Pulmonary hypertension related to left heart disease: insight from a wireless implantable hemodynamic monitor. J Heart Lung Transplant 2015 34 329 337. doi: 10.1016/j.healun.2014.04.014
4. Butler J, Chomsky DB, Wilson JR, Pulmonary hypertension and exercise intolerance in patients with heart failure. J Am Coll Cardiol 1999 34 1802 1806. doi: 10.1016/S0735-1097(99)00408-8
5. Ghio S, Gavazzi A, Campana C, Inserra C, Klersy C, Sebastiani R, Arbustini E, Recusani F, Tavazzi L, Independent and additive prognostic value of right ventricular systolic function and pulmonary artery pressure in patients with chronic heart failure. J Am Coll Cardiol 2001 37 183 188. doi: 10.1016/S0735-1097(00)01102-5
6. Di Salvo TG, Mathier M, Semigran MJ, Dec GW, Preserved right ventricular ejection fraction predicts exercise capacity and survival in advanced heart failure. J Am Coll Cardiol 1995 25 1143 1153. doi: 10.1016/0735-1097(94)00511-N
7. Lam CS, Roger VL, Rodeheffer RJ, Borlaug BA, Enders FT, Redfield MM, Pulmonary hypertension in heart failure with preserved ejection fraction: a community-based study. J Am Coll Cardiol 2009 53 1119 1126. doi: 10.1016/j.jacc.2008.11.051
8. Leung CC, Moondra V, Catherwood E, Andrus BW, Prevalence and risk factors of pulmonary hypertension in patients with elevated pulmonary venous pressure and preserved ejection fraction. Am J Cardiol 2010 106 284 286. doi: 10.1016/j.amjcard.2010.02.039
9. Damy T, Kallvikbacka-Bennett A, Goode K, Khaleva O, Lewinter C, Hobkirk J, Nikitin NP, Dubois-Randé JL, Hittinger L, Clark AL, Cleland JG, Prevalence of, associations with, and prognostic value of tricuspid annular plane systolic excursion (TAPSE) among out-patients referred for the evaluation of heart failure. J Card Fail 2012 18 216 225. doi: 10.1016/j.cardfail.2011.12.003
10. Mohammed SF, Hussain I, AbouEzzeddine OF, Abou Ezzeddine OF, Takahama H, Kwon SH, Forfia P, Roger VL, Redfield MM, Right ventricular function in heart failure with preserved ejection fraction: a community-based study. Circulation 2014 130 2310 2320. doi: 10.1161/CIRCULATIONAHA.113.008461
11. Naeije R, Chesler N, Pulmonary circulation at exercise. Compr Physiol 2012 2 711 741. doi: 10.1002/cphy.c100091
12. Naeije R, Vanderpool R, Dhakal BP, Saggar R, Saggar R, Vachiery JL, Lewis GD, Exercise-induced pulmonary hypertension: physiological basis and methodological concerns. Am J Respir Crit Care Med 2013 187 576 583. doi: 10.1164/rccm.201211-2090CI
13. Linehan JH, Haworth ST, Nelin LD, Krenz GS, Dawson CA, A simple distensible vessel model for interpreting pulmonary vascular pressure-flow curves. J Appl Physiol (1985) 1992 73 987 994
14. Reeves JT, Linehan JH, Stenmark KR, Distensibility of the normal human lung circulation during exercise. Am J Physiol Lung Cell Mol Physiol 2005 288 L419 L425. doi: 10.1152/ajplung.00162.2004
15. Frise MC, Robbins PA, The pulmonary vasculature-lessons from Tibetans and from rare diseases of oxygen sensing. Exp Physiol 2015 100 1233 1241. doi: 10.1113/expphysiol.2014.080507
16. Ghio S, Schirinzi S, Pica S, Pulmonary arterial compliance: how and why should we measure it? Glob Cardiol Sci Pract 2015 2015 58. doi: 10.5339/gcsp.2015.58
17. Sanz J, Kariisa M, Dellegrottaglie S, Prat-González S, Garcia MJ, Fuster V, Rajagopalan S, Evaluation of pulmonary artery stiffness in pulmonary hypertension with cardiac magnetic resonance. JACC Cardiovasc Imaging 2009 2 286 295. doi: 10.1016/j.jcmg.2008.08.007
18. Kang KW, Chang HJ, Kim YJ, Choi BW, Lee HS, Yang WI, Shim CY, Ha J, Chung N, Cardiac magnetic resonance imaging-derived pulmonary artery distensibility index correlates with pulmonary artery stiffness and predicts functional capacity in patients with pulmonary arterial hypertension. Circ J 2011 75 2244 2251. doi: 10.1253/circj.CJ-10-1310
19. Swift AJ, Rajaram S, Condliffe R, Capener D, Hurdman J, Elliot C, Kiely DG, Wild JM, Pulmonary artery relative area change detects mild elevations in pulmonary vascular resistance and predicts adverse outcome in pulmonary hypertension. Invest Radiol 2012 47 571 577. doi: 10.1097/RLI.0b013e31826c4341
20. Bogren HG, Klipstein RH, Mohiaddin RH, Firmin DN, Underwood SR, Rees RS, Longmore DB, Pulmonary artery distensibility and blood flow patterns: a magnetic resonance study of normal subjects and of patients with pulmonary arterial hypertension. Am Heart J 1989 118 5 pt 1 990 999
21. Pasierski TJ, Starling RC, Binkley PF, Pearson AC, Echocardiographic evaluation of pulmonary artery distensibility. Chest 1993 103 1080 1083. doi: 10.1378/chest.103.4.1080
22. Revel MP, Faivre JB, Remy-Jardin M, Delannoy-Deken V, Duhamel A, Remy J, Pulmonary hypertension: ECG-gated 64-section CT angiographic evaluation of new functional parameters as diagnostic criteria. Radiology 2009 250 558 566. doi: 10.1148/radiol.2502080315
23. Kasai H, Sugiura T, Tanabe N, Sakurai Y, Yahaba M, Matsuura Y, Shigeta A, Kawata N, Sakao S, Kasahara Y, Tatsumi K, Electrocardiogram-gated 320-slice multidetector computed tomography for the measurement of pulmonary arterial distensibility in chronic thromboembolic pulmonary hypertension. PLoS One 2014 9 e111563. doi: 10.1371/journal.pone.0111563
24. Lau EM, Iyer N, Ilsar R, Bailey BP, Adams MR, Celermajer DS, Abnormal pulmonary artery stiffness in pulmonary arterial hypertension: in vivo study with intravascular ultrasound. PLoS One 2012 7 e33331. doi: 10.1371/journal.pone.0033331
25. Bellofiore A, Henningsen J, Lepak CG, Tian L, Roldan-Alzate A, Kellihan HB, Consigny DW, Francois CJ, Chesler NC, A novel in vivo approach to assess radial and axial distensibility of large and intermediate pulmonary artery branches. J Biomech Eng 2015 137 044501. doi: 10.1115/1.4029578
26. Lalande S, Yerly P, Faoro V, Naeije R, Pulmonary vascular distensibility predicts aerobic capacity in healthy individuals. J Physiol 2012 590 4279 4288. doi: 10.1113/jphysiol.2012.234310
27. Abraham WT, Adamson PB, Bourge RC, Aaron MF, Costanzo MR, Stevenson LW, Strickland W, Neelagaru S, Raval N, Krueger S, Weiner S, Shavelle D, Jeffries B, Yadav JS, CHAMPION Trial Study Group Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial. Lancet 2011 377 658 666. doi: 10.1016/S0140-6736(11)60101-3
28. Wasserman K, Hansen JE, Sue DY, Stringer WW, Whipp BJ, Principles of Exercise Testing and Interpretation 2005 Philadelphia, PA Lippincott Williams & Wilkins
29. Hansen JE, Sue DY, Wasserman K, Predicted values for clinical exercise testing. Am Rev Respir Dis 1984 129 2 pt 2 S49 S55. doi: 10.1164/arrd.1984.129.2P2.S49
30. Gandevia B, Hugh-Jones P, Terminology for measurements of ventilatory capacity; a report to the thoracic society. Thorax 1957 12 290 293. doi: 10.1136/thx.12.4.290
31. Dhakal BP, Malhotra R, Murphy RM, Pappagianopoulos PP, Baggish AL, Weiner RB, Houstis NE, Eisman AS, Hough SS, Lewis GD, Mechanisms of exercise intolerance in heart failure with preserved ejection fraction: the role of abnormal peripheral oxygen extraction. Circ Heart Fail 2015 8 286 294. doi: 10.1161/CIRCHEARTFAILURE.114.001825
32. Lewis GD, Lachmann J, Camuso J, Lepore JJ, Shin J, Martinovic ME, Systrom DM, Bloch KD, Semigran MJ, Sildenafil improves exercise hemodynamics and oxygen uptake in patients with systolic heart failure. Circulation 2007 115 59 66. doi: 10.1161/CIRCULATIONAHA.106.626226
33. Lewis GD, Shah R, Shahzad K, Camuso JM, Pappagianopoulos PP, Hung J, Tawakol A, Gerszten RE, Systrom DM, Bloch KD, Semigran MJ, Sildenafil improves exercise capacity and quality of life in patients with systolic heart failure and secondary pulmonary hypertension. Circulation 2007 116 1555 1562. doi: 10.1161/CIRCULATIONAHA.107.716373
34. Stringer WW, Hansen JE, Wasserman K, Cardiac output estimated noninvasively from oxygen uptake during exercise. J Appl Physiol (1985) 1997 82 908 912
35. Agostoni PG, Wasserman K, Perego GB, Guazzi M, Cattadori G, Palermo P, Lauri G, Marenzi G, Non-invasive measurement of stroke volume during exercise in heart failure patients. Clin Sci (Lond) 2000 98 545 551. doi: 10.1042/cs0980545
36. Finch CA, Lenfant C, Oxygen transport in man. N Engl J Med 1972 286 407 415. doi: 10.1056/NEJM197202242860806
37. Owan TE, Hodge DO, Herges RM, Jacobsen SJ, Roger VL, Redfield MM, Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med 2006 355 251 259. doi: 10.1056/NEJMoa052256
38. Bhella PS, Prasad A, Heinicke K, Hastings JL, Arbab-Zadeh A, Adams-Huet B, Pacini EL, Shibata S, Palmer MD, Newcomer BR, Levine BD, Abnormal haemodynamic response to exercise in heart failure with preserved ejection fraction. Eur J Heart Fail 2011 13 1296 1304. doi: 10.1093/eurjhf/hfr133
39. Mancini DM, Eisen H, Kussmaul W, Mull R, Edmunds LH Jr, Wilson JR, Value of peak exercise oxygen consumption for optimal timing of cardiac transplantation in ambulatory patients with heart failure. Circulation 1991 83 778 786. doi: 10.1161/01.CIR.83.3.778
40. Lau EM, Chemla D, Godinas L, Zhu K, Sitbon O, Savale L, Montani D, Jaïs X, Celermajer DS, Simonneau G, Humbert M, Hervé P, Loss of vascular distensibility during exercise is an early hemodynamic marker of pulmonary vascular disease. Chest 2016 149 353 361. doi: 10.1378/chest.15-0125
41. Lewis GD, Murphy RM, Shah RV, Pappagianopoulos PP, Malhotra R, Bloch KD, Systrom DM, Semigran MJ, Pulmonary vascular response patterns during exercise in left ventricular systolic dysfunction predict exercise capacity and outcomes. Circ Heart Fail 2011 4 276 285. doi: 10.1161/CIRCHEARTFAILURE.110.959437
42. Borlaug BA, Nishimura RA, Sorajja P, Lam CS, Redfield MM, Exercise hemodynamics enhance diagnosis of early heart failure with preserved ejection fraction. Circ Heart Fail 2010 3 588 595. doi: 10.1161/CIRCHEARTFAILURE.109.930701
43. Argiento P, Vanderpool RR, Mulè M, Russo MG, D'Alto M, Bossone E, Chesler NC, Naeije R, Exercise stress echocardiography of the pulmonary circulation: limits of normal and sex differences. Chest 2012 142 1158 1165. doi: 10.1378/chest.12-0071
44. Stevens GR, Garcia-Alvarez A, Sahni S, Garcia MJ, Fuster V, Sanz J, RV dysfunction in pulmonary hypertension is independently related to pulmonary artery stiffness. JACC Cardiovasc Imaging 2012 5 378 387. doi: 10.1016/j.jcmg.2011.11.020
45. Baker BJ, Wilen MM, Boyd CM, Dinh H, Franciosa JA, Relation of right ventricular ejection fraction to exercise capacity in chronic left ventricular failure. Am J Cardiol 1984 54 596 599
46. Shao Z, Wang Z, Shrestha K, Thakur A, Borowski AG, Sweet W, Thomas JD, Moravec CS, Hazen SL, Tang WH, Pulmonary hypertension associated with advanced systolic heart failure: dysregulated arginine metabolism and importance of compensatory dimethylarginine dimethylaminohydrolase-1. J Am Coll Cardiol 2012 59 1150 1158. doi: 10.1016/j.jacc.2011.12.022
47. Galiè N, Manes A, Branzi A, Prostanoids for pulmonary arterial hypertension. Am J Respir Med 2003 2 123 137
48. Moraes DL, Colucci WS, Givertz MM, Secondary pulmonary hypertension in chronic heart failure: the role of the endothelium in pathophysiology and management. Circulation 2000 102 1718 1723. doi: 10.1161/01.CIR.102.14.1718
49. Dupuis J, Guazzi M, Pathophysiology and clinical relevance of pulmonary remodelling in pulmonary hypertension due to left heart diseases. Can J Cardiol 2015 31 416 429. doi: 10.1016/j.cjca.2014.10.012
50. Redfield MM, Chen HH, Borlaug BA, Semigran MJ, Lee KL, Lewis G, LeWinter MM, Rouleau JL, Bull DA, Mann DL, Deswal A, Stevenson LW, Givertz MM, Ofili EO, O'Connor CM, Felker GM, Goldsmith SR, Bart BA, McNulty SE, Ibarra JC, Lin G, Oh JK, Patel MR, Kim RJ, Tracy RP, Velazquez EJ, Anstrom KJ, Hernandez AF, Mascette AM, Braunwald E, RELAX Trial Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: a randomized clinical trial. JAMA 2013 309 1268 1277. doi: 10.1001/jama.2013.2024